A Randomized PhaseII Trial of Neo-Adjuvant Chemotherapy with Metformin or Placebo for HER2 Positive Operable Breast Cancer The HERMET Trial
Old Title: Randomized Trial of Neo-Adjuvant Chemotherapy with or without Metformin for HER2 Positive Operable Breast Cancer, The HERMET Trial
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score
A Randomized, Multicenter, Double-Blind Phase III Study of SAR439859 Plus Palbociclib Versus Letrozole Plus Palbociclib For the Treatment of Patients with ER +, HER2 - Breast Cancer Who Have Not Received Any Prior Systemic Anti-Cancer Treatment for Advanced Disease
An Open-Label Randomized Phase II Trial of SAR439859, Versus Endocrine Monotherapy as Per Physician?s Choice in Patients with Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer with Prior Exposure to Hormonal Therapies AMEERA 3
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer